被引量: 1485发表: 2005年 The metabolic syndrome: a global public health problem and a new definition. The constellation of metabolic abnormalities including centrally distributed obesity, decreased high-density lipoprotein cholesterol (HDL-C), elevated trig... P Zimmet,D Magliano,Y Matsuzawa,... ...
(IDF)-indicated criteria in the elderly, characterized by a decrease of several normal values, the neglected evaluation of those values with aging, and an eventual decision of an obligatory consideration of the visceral obesity as a sign of the metabolic syndrome (MS), the relative prevalence of...
1. The Global Burden of the Metabolic Syndrome and its Consequences for Diabetes and Cardiovascular Disease (Sarah H. Wild and Christopher D. Byrne). Introduction. Definition of the metabolic syndrome. Available data on prevalence of the metabolic syndrome. Factors that influence prevalence of the ...
出版年:2011-8 页数:384 定价:£ 74.99 ISBN:9781444336580 豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 内容简介· ··· The Metabolic Syndrome is a valuable reference text, covering all aspects of the metabolic syndrome and its constituent diseases including inflammation, oxidation...
Ruiz-Torres A. Aging and the Metabolic Syndrome. In: Serrano Rios M, Caro JF, Carraro R, Gutierrez Fuentes JA, eds. The Metabolic Syndrome at the beginning of the XXIst century. A genetic and molecular approach. Elsevier Espana, pp. 83-91. Madrid, 2005....
Metabolic syndrome (MS) is a complex clinical condition, characterised by a constellation of different metabolic and cardiovascular traits, typically high blood pressure, abdominal obesity, lipid profile abnormalities, insulin resistance and glucose intolerance. More recently, other features have been propose...
被引量: 903发表: 2005年 Prevalence and characteristics of the metabolic syndrome among adults in Beijing, China. LI G,D E COURTEN M,JIAO S,et al.Prevalence and characteristics of the metabolic syndrome among adults in Beijing,China[J].Asia Pac J Clin Nutr,... G Li,MD Courten,SF Jiao...
Metab. 90, 712–719 (2005). Article CAS PubMed Google Scholar Bojesen, A., Host, C. & Gravholt, C. H. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition. Mol. Hum. Reprod. 16, 396–401 (2010). Article PubMed Google Scholar ...
31 IL-6 concentrations less than 2.5 pg/mL have been shown to reduce the risk of mobility disability and improve markers of metabolic syndrome.32 Participants in all 3 groups exceeded this level (mean, 3.1 pg/mL) at baseline, with significant improvements in D+E and D relative to E at ...
Fievet C, Fruchart JC, Staels B: PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Current opinion in pharmacology. 2006, 6 (6): 606-614. 10.1016/j.coph.2006.06.009. Article CAS PubMed Google Scholar Easton DP, Kaneko Y, Subjeck...